Gilead Sciences Inc
XMUN:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
XMUN:GIS
|
US |
|
F
|
Fresnillo PLC
F:FNL
|
MX |
|
A
|
Alpha Services and Holdings SA
XMUN:ACBB
|
GR |
|
E
|
Electronic Arts Inc
SWB:ERT
|
US |
|
Q
|
Qiagen NV
XMUN:QIA
|
NL |
|
O
|
Otto Energy Ltd
F:O1E
|
AU |
|
B
|
Bayan Resources Tbk PT
XMUN:BNB
|
ID |
|
Alphamin Resources Corp
F:21L
|
MU |
|
P
|
Prosus NV
LSE:0A28
|
NL |
|
T
|
thyssenkrupp AG
DUS:TKA
|
DE |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
Hitachi Ltd
F:HIA1
|
JP |
|
Grifols SA
OTC:GIKLY
|
ES |
|
K
|
Kawasaki Kisen Kaisha Ltd
F:KLI
|
JP |
|
E
|
Equity Residential
F:EQR
|
US |
|
W
|
Williams Companies Inc
F:WMB
|
US |
|
R
|
Raytheon Technologies Corp
F:5UR
|
US |
|
Arctic Paper SA
F:A0P
|
PL |
|
Prosus NV
F:1TY
|
NL |
|
Telkom Indonesia (Persero) Tbk PT
F:PTI
|
ID |
|
C
|
Commerzbank AG
F:ZZMS
|
DE |
|
E
|
Estee Lauder Companies Inc
VSE:ESLA
|
US |
Bankruptcy Probability
Gilead Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gilead Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
406.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
111.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
88.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
29.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gilead Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gilead Sciences Inc has total debt of 20.9B USD. This includes both short-term (0 USD) and long-term (20.9B USD) debt.
You can find a full breakdown on its Balance Sheet.
